Randomized phase 3 trial of ombitasvir/paritaprevir/ritonavir for hepatitis C virus genotype 1b–infected Japanese patients with or without cirrhosis

Publisher: John Wiley & Sons Inc

E-ISSN: 1527-3350|62|4|1037-1046

ISSN: 0270-9139

Source: HEPATOLOGY, Vol.62, Iss.4, 2015-10, pp. : 1037-1046

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content